Dr. Tan welcomes the newest editorial board member and shares her must-reads from the April issue.
I first want to extend an official welcome to Russell Libby, MD, the latest addition to our Editorial Advisory Board. Dr. Libby is the chief of general pediatrics at Inova Children’s Hospital in Falls Church, Virginia, and founder and president of the Virginia Pediatric Group. He brings incredible passion and talent to the Editorial Board.
The coronavirus disease 2019 pandemic has been ongoing for over a year and one of its major negative impacts has been on the mental health and wellbeing of children and adolescents. The stressors of the pandemic have caused a significant increase in anxiety, depression, and sleep disturbance, and an exacerbation of underlying mental health conditions, especially among adolescents. These may present in a variety of ways, and pediatric care providers should be on the lookout for signs of a potentially serious issue so they can refer their patients to the appropriate mental health services.
This month, Contemporary Pediatrics has several must-read articles:
Our cover story on atopic dermatitis is an excellent review of this very common childhood condition. The authors discuss presenting symptoms, new drugs, and new protocols for treatment.
April’s Puzzler, the Developmental Health column on energy deficiency in young athletes, and our special section on advising teenagers on drugs all cover very real issues relating to the adolescent population, many of which have worsened during the pandemic.
In our Nutrition section, we cover the very practical and timely topic of plant-based protein vs animal protein diets in children.
Thank you for continuing to provide outstanding care to your patients during these challenging times. As Susan J. Bissonette said, “An optimist is the human personification of spring.”
Please stay safe and well. And, as always, I welcome your suggestions, comments, and questions.
With warmest regards,
Tina
Tina Q. Tan., MD, FAAP, FIDSA, FPIDS
Editor-in-Chief
Fluoxetine helps refractory nocturnal enuresis but not for long
March 29th 2023A 12-week study in Egypt of the efficacy of fluoxetine (a selective serotonin reuptake inhibitor) in children with treatment-refractory nocturnal enuresis (NE) found that though the treatment achieved a good initial response, it was not sustainable.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.
Are some patients predisposed to avascular necrosis after hip surgery?
March 14th 2023Although avascular necrosis (AVN) is believed to be an iatrogenic complication following treatment of developmental dysplasia of the hip, an investigation in China found 2 characteristics associated with the condition: the likelihood of AVN increases with both the grade of dislocation and of underdevelopment of the ossific nucleus.
Meet the board: Jessica L. Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN
April 22nd 2022In the latest episode of our podcast series, Jessica L. Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN shares why she got into medicine, the myths of pediatric, and what the future may hold for the specialty.